Middle hepatic vein variation provides a safe path for anterior transection of hepatocellular carcinoma in caudate lobe

doi:10.1016/j.hbpd.2023.05.002

Abstract
Figure/Table
References (0)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Hepatocellular carcinoma (HCC) is one of the main causes of cancer related death worldwide, and new cases are expected to continue to increase in future [1] . Surgical resection is still the best way to remove the tumor and improve patient’s prognosis. However, resection of caudate lobe often presents a technical challenge, even to accomplished hepatic surgeons. Caudate lobe is located anterior to the inferior vena cava (IVC) and posterior to the bifurcation of the portal vein (PV), generally consists of three regions: the paracaval portion, the left Spiegel lobe and the process portion [2] . The anatomy of the paracaval portion includes the liver parenchyma ventral to the hepatic IVC and the area between the Spiegel lobe and the right lobe adjacent to the middle hepatic vein (MHV) ventrally, which was classified by Couinaud as segment IX [3] . Here, we presented a case of HCC with successful downstaging therapy, as well as variation of MHV, which provides a safe path for anterior transection of segment IX.

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles in this journal by
	Lin BY
	Zhang QJ
	Yang Z
	Zheng SS

Cite this article:

Lin BY, Zhang QJ, Yang Z, et al. Middle hepatic vein variation provides a safe path for anterior transection of hepatocellular carcinoma in caudate lobe. Hepatobiliary Pancreat Dis Int 2024; 23(4): 438-440. DOI:10.1016/j.hbpd.2023.05.002

URL:

http://dx.doi.org/10.1016/j.hbpd.2023.05.002 OR http://www.hbpdint.com/EN/Y2024/V23/I4/438